Live Breaking News & Updates on American College Of Rheumatology Convergence

Stay updated with breaking news from American college of rheumatology convergence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Push to 'repair the mitochondria' may revolutionize rheumatoid arthritis treatment

Push to 'repair the mitochondria' may revolutionize rheumatoid arthritis treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Corneliam-weyand , Shenaz-bagha , Byrob-volansky , Stanford-university-school-of-medicine , Mayo-clinic-college-of-medicine , American-college-of-rheumatology-convergence , American-college , Rheumatology-convergence , Mayo-clinic-college , Stanford-university-school , Klemperer-memorial-lecture , Mitochondrial-disease

Implications for pathophysiology and therapeutics in chronic inflammatory disorder

This article explores the role of citrullination, a post-translational modification process, in the pathogenesis of chronic diseases such as rheumatoid arthritis, cancer, and neurodegenerative disorders ....

Ireland , United-states , San-diego , California , Maria-osipova , Sonoma-biotherapeutics , Sengenics-corporation , Cancer-research , Sengenics-corporation-llcapr , American-college-of-rheumatology , American-college-of-rheumatology-convergence , Autoimmune-autoantigen-panel

Aurinia Submits IND Application to US Food & Drug Administration for AUR 200

AUR200, a potent recombinant fusion protein, has a clinically validated MOA with a high affinity for targeting both BAFF and APRIL

Upon FDA clearance of the IND, AUR 200 will be studied in a. ....

Maryland , United-states , Rockville , Volker-knappertz , Research-development , Nasdaq , Drug-administration , American-college-of-rheumatology-convergence , Aurinia-pharmaceuticals , Aurinia-pharmaceuticals-inc , Investigational-new-drug , B-cell-activating-factor

Aurinia Pharmaceuticals Inc. Submits IND Application to US Food & Drug Administration for AUR 200

Aurinia Pharmaceuticals Inc. announced the submission of its Investigational New Drug application to the U.S. Food and Drug Administration for AUR200, a potential next generation therapy for B-cell. ....

Drug-administration , Aurinia-pharmaceuticals-inc , American-college-of-rheumatology-convergence , Aurinia-pharmaceuticals , Investigational-new-drug , B-cell-activating-factor , Proliferation-inducing-ligand , American-college , Rheumatology-convergence , Markets ,

Aurinia Pharmaceuticals (AUPH) Submits IND Application to the FDA for AUR 200

Aurinia Pharmaceuticals (AUPH) Submits IND Application to the FDA for AUR 200
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Volker-knappertz , American-college-of-rheumatology-convergence , Aurinia-pharmaceuticals-inc , Research-development , Drug-administration , Nasdaq , Aurinia-pharmaceuticals , Investigational-new-drug , B-cell-activating-factor , Proliferation-inducing-ligand , Executive-vice-president , American-college